SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950135-04-002058
Filing Date
2004-04-27
Accepted
2004-04-27 17:18:22
Documents
3
Period of Report
2004-04-27
Items
Item 5: Other events
Item 7: Financial statements and exhibits

Document Format Files

Seq Description Document Type Size
1 TRANSKARYOTIC THERAPIES, INC b50440k2e8vk.htm 8-K 12144
2 EX-25.1 FORM T-1 b50440k2exv25w1.htm EX-25.1 33284
3 EX-99.1 PRESS RELEASE DATED APRIL 27, 2004 b50440k2exv99w1.htm EX-99.1 4478
  Complete submission text file 0000950135-04-002058.txt   51665
Mailing Address
Business Address 195 ALBANY ST CAMBRIDGE MA 02139 6173490200
TRANSKARYOTIC THERAPIES INC (Filer) CIK: 0000885259 (see all company filings)

IRS No.: 043027191 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-21481 | Film No.: 04757768
SIC: 2836 Biological Products, (No Diagnostic Substances)